-+ 0.00%
-+ 0.00%
-+ 0.00%

Truist Securities Maintains Buy on Medline, Lowers Price Target to $47

Benzinga·08/06/2026 16:04:26
Listen to the news
Truist Securities analyst Jailendra Singh maintains Medline (NASDAQ:MDLN) with a Buy and lowers the price target from $56 to $47.